Genome research usually doesn't sequence entire genomes. Craig Venter thinks this has limited medical gains so far and, with a $70 million investment, aims to revolutionize the field.
from WSJ.com: US Business http://ift.tt/1f2dL5r
via IFTTT
from WSJ.com: US Business http://ift.tt/1f2dL5r
via IFTTT
No comments:
Post a Comment